Abstract We evaluated the potential antiviral effects of azithromycin on the nasopharyngeal virome of Nigerien children who had received multiple rounds of mass drug administration. We found that the respiratory burden of non–severe acute respiratory syndrome coronaviruses was decreased with azithromycin distributions. Clinical Trials Registration . NCT02047981.
All Keywords
【저자키워드】 coronavirus, Azithromycin, children, virome, Niger, 【초록키워드】 coronavirus, Azithromycin, Antiviral effect, Registration, nasopharyngeal, clinical, respiratory, acute respiratory syndrome, Drug administration, distributions, evaluated, 【제목키워드】 coronavirus, Azithromycin, burden, mass,
【저자키워드】 coronavirus, Azithromycin, children, virome, Niger, 【초록키워드】 coronavirus, Azithromycin, Antiviral effect, Registration, nasopharyngeal, clinical, respiratory, acute respiratory syndrome, Drug administration, distributions, evaluated, 【제목키워드】 coronavirus, Azithromycin, burden, mass,
초록 우리는 여러 차례의 대량 약물 투여를 받은 나이지리아 어린이의 비인두 바이롬에 대한 아지스로마이신의 잠재적인 항바이러스 효과를 평가했습니다. 우리는 심각하지 않은 급성 호흡기 증후군 코로나바이러스의 호흡 부담이 아지스로마이신 분포로 감소한다는 것을 발견했습니다. 임상 시험 등록 . NCT02047981.